Pancreatic cancer stem cells: features and detection methods

doi:10.1007/s12253-018-0420-x

Review

. 2018 Oct;24(4):797-805.

doi: 10.1007/s12253-018-0420-x. Epub 2018 Jun 8.

Pancreatic cancer stem cells: features and detection methods

Toshiyuki Ishiwata¹, Yoko Matsuda², Hisashi Yoshimura³, Norihiko Sasaki⁴, Shunji Ishiwata⁵, Naoshi Ishikawa⁶, Kaiyo Takubo⁶, Tomio Arai², Junko Aida⁶

Affiliations

¹ Division of Aging and Carcinogenesis, Research Team for Geriatric Pathology, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, 173-0015, Japan. tishiwat@tmig.or.jp.
² Department of Pathology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, 173-0015, Japan.
³ Department of Applied Science, School of Veterinary Nursing and Technology, Nippon Veterinary and Life Science University, Tokyo, 180-0022, Japan.
⁴ Research Team for Geriatric Medicine (Vascular Medicine), Tokyo Metropolitan Institute of Gerontology, Tokyo, 173-0015, Japan.
⁵ Division of Medical Pharmaceutics & Therapeutics, Faculty of Pharmacy, Kindai University, 3-4-1 Kowakae, Higashi-Osaka, Osaka, 577-8502, Japan.
⁶ Division of Aging and Carcinogenesis, Research Team for Geriatric Pathology, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, 173-0015, Japan.

PMID: 29948612
DOI: 10.1007/s12253-018-0420-x

Free article

Review

Pancreatic cancer stem cells: features and detection methods

Toshiyuki Ishiwata et al. Pathol Oncol Res. 2018 Oct.

Free article

. 2018 Oct;24(4):797-805.

doi: 10.1007/s12253-018-0420-x. Epub 2018 Jun 8.

Authors

Toshiyuki Ishiwata¹, Yoko Matsuda², Hisashi Yoshimura³, Norihiko Sasaki⁴, Shunji Ishiwata⁵, Naoshi Ishikawa⁶, Kaiyo Takubo⁶, Tomio Arai², Junko Aida⁶

Affiliations

¹ Division of Aging and Carcinogenesis, Research Team for Geriatric Pathology, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, 173-0015, Japan. tishiwat@tmig.or.jp.
² Department of Pathology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, 173-0015, Japan.
³ Department of Applied Science, School of Veterinary Nursing and Technology, Nippon Veterinary and Life Science University, Tokyo, 180-0022, Japan.
⁴ Research Team for Geriatric Medicine (Vascular Medicine), Tokyo Metropolitan Institute of Gerontology, Tokyo, 173-0015, Japan.
⁵ Division of Medical Pharmaceutics & Therapeutics, Faculty of Pharmacy, Kindai University, 3-4-1 Kowakae, Higashi-Osaka, Osaka, 577-8502, Japan.
⁶ Division of Aging and Carcinogenesis, Research Team for Geriatric Pathology, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, 173-0015, Japan.

PMID: 29948612
DOI: 10.1007/s12253-018-0420-x

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a high incidence of distant metastasis and recurrence. Cancer stem cells (CSCs), which are pluripotent, self-renewable, and capable of forming tumors, contribute to PDAC initiation and metastasis and are responsible for resistance to chemotherapy and radiation. Three types of experimental methods are commonly used to identify CSCs: CSC-specific marker detection, a sphere-formation assay that reveals cell proliferation under non-adherent conditions, and detection of side-population (SP) cells that possess high intracellular-to-extracellular pump functions. Several CSC-specific markers have been reported in PDACs, including CD133, CD24, CD44, CXCR4, EpCAM, ABCG2, c-Met, ALDH-1, and nestin. There remains controversy regarding which markers are specific to PDAC CSCs and which are expressed alone or in combination in CSCs. Examining characteristics of isolated CSCs and discovering CSC-specific treatment options are important to improve the prognosis of PDAC cases. This review summarizes CSC-detection methods for PDAC, including CSC-marker detection, the sphere-formation assay, and detection of SP cells.

Keywords: Cancer stem cell marker; Cancer stem cell/CSC; Pancreatic cancer; Side population; Sphere.

PubMed Disclaimer

Cited by

Fatty acid oxidation is critical for the tumorigenic potential and chemoresistance of pancreatic cancer stem cells.
Mascaraque M, Courtois S, Royo-García A, Barneda D, Stoian AM, Villaoslada I, Espiau-Romera P, Bokil A, Cano-Galiano A, Jagust P, Heeschen C, Sancho P. Mascaraque M, et al. J Transl Med. 2024 Aug 28;22(1):797. doi: 10.1186/s12967-024-05598-6. J Transl Med. 2024. PMID: 39198858 Free PMC article.
Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting.
Bisht S, Nigam M, Kunjwal SS, Sergey P, Mishra AP, Sharifi-Rad J. Bisht S, et al. Stem Cells Int. 2022 Jun 28;2022:9653244. doi: 10.1155/2022/9653244. eCollection 2022. Stem Cells Int. 2022. PMID: 35800881 Free PMC article. Review.
GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma.
Jo JH, Kim SA, Lee JH, Park YR, Kim C, Park SB, Jung DE, Lee HS, Chung MJ, Song SY. Jo JH, et al. BMC Cancer. 2021 Nov 18;21(1):1241. doi: 10.1186/s12885-021-08898-y. BMC Cancer. 2021. PMID: 34794402 Free PMC article.
Identification and Prognostic Value Exploration of Radiotherapy Sensitivity-Associated Genes in Non-Small-Cell Lung Cancer.
Ma Q, Geng K, Xiao P, Zeng L. Ma Q, et al. Biomed Res Int. 2021 Sep 2;2021:5963868. doi: 10.1155/2021/5963868. eCollection 2021. Biomed Res Int. 2021. PMID: 34518802 Free PMC article.
Role of RNA methylation in the regulation of pancreatic cancer stem cells (Review).
Tsuji Y, Hara T, Meng S, Sato H, Arao Y, Ofusa K, Ishii H. Tsuji Y, et al. Oncol Lett. 2023 Jun 20;26(2):336. doi: 10.3892/ol.2023.13922. eCollection 2023 Aug. Oncol Lett. 2023. PMID: 37427348 Free PMC article. Review.

See all "Cited by" articles

References

1. Am J Pathol. 2014 Mar;184(3):674-85 - PubMed
1. Prostate. 2008 Jun 15;68(9):1007-24 - PubMed
1. World J Gastroenterol. 2008 Feb 14;14(6):925-30 - PubMed
1. Cancer Res. 2011 Mar 15;71(6):2328-38 - PubMed
1. Expert Opin Biol Ther. 2009 Oct;9(10):1271-8 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

JP16K10613/JSPS KAKENHI

LinkOut - more resources

Full Text Sources
- Hungarian Oncological Association
- Springer
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

[1] Am J Pathol. 2014 Mar;184(3):674-85 - PubMed

[2] Am J Pathol. 2014 Mar;184(3):674-85 - PubMed

[3] Prostate. 2008 Jun 15;68(9):1007-24 - PubMed

[4] Prostate. 2008 Jun 15;68(9):1007-24 - PubMed

[5] World J Gastroenterol. 2008 Feb 14;14(6):925-30 - PubMed

[6] World J Gastroenterol. 2008 Feb 14;14(6):925-30 - PubMed

[7] Cancer Res. 2011 Mar 15;71(6):2328-38 - PubMed

[8] Cancer Res. 2011 Mar 15;71(6):2328-38 - PubMed

[9] Expert Opin Biol Ther. 2009 Oct;9(10):1271-8 - PubMed

[10] Expert Opin Biol Ther. 2009 Oct;9(10):1271-8 - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Pancreatic cancer stem cells: features and detection methods

Affiliations

Pancreatic cancer stem cells: features and detection methods

Authors

Affiliations

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Research Materials

Miscellaneous